You are here

Biopharma firm AbbVie opens S$400m biologics plant in Tuas

The 120,000-sq metre facility, its first manufacturing plant in Asia, will create 250 jobs

BT_20171005_ABBVIE_3116816.jpg
(From far left): Site director Marc O'Donoghue, chairman of the Singapore Economic Development Board Beh Swan Gin, Trade and Industry Minister S Iswaran, chairman and chief executive of AbbVie Richard Gonzalez, senior vice-president of operations at AbbVie Azita Saleki-Gerhardt and vice-president of manufacturing operations Biologic at AbbVie Daniela Ottini.

Singapore

GLOBAL research and development-based bio-pharmaceutical company AbbVie has enlarged its footprint in Singapore.

On Wednesday, it opened a new biologics manufacturing plant in Tuas, which will expand its manufacturing capabilities for biologics, which are commercial...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes